Genetic Susceptibility for Coronary Heart Disease and Type 2 Diabetes Complications

被引：5
|
作者：
Kalea, Anastasia Z. [1 ]
Harrison, Seamus C. [1 ]
Stephens, Jeffrey W. [2 ]
Talmud, Philippa J. [1 ]
机构：
[1] UCL, Ctr Cardiovasc Genet, Inst Cardiovasc Sci, London WC1E 6JF, England
[2] Swansea Univ, Diabet Res Grp, Inst Life Sci, Sch Med, Swansea, W Glam, Wales
来源：
CLINICAL CHEMISTRY | 2012年 / 58卷 / 05期
关键词：
RISK; UTILITY;
D O I：
10.1373/clinchem.2012.182725
中图分类号：
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号：
1001 ;
摘要：
引用
收藏
页码：818 / 820
页数：3
相关论文
共 50 条
  • [21] Association of ACE and MTHFR genetic polymorphisms with type 2 diabetes mellitus: Susceptibility and complications
    Settin, Ahmad
    El-Baz, Rizk
    Ismaeel, Azza
    Tolba, Wafaa
    Allah, Wafaa A.
    JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM, 2015, 16 (04) : 838 - 843
  • [22] Asymptomatic coronary heart disease in patients with type 2 diabetes with vascular complications: a cross-sectional study
    Tsujimoto, Tetsuro
    Kajio, Hiroshi
    Takahashi, Yoshihiko
    Kishimoto, Miyako
    Noto, Hiroshi
    Yamamoto-Honda, Ritsuko
    Kamimura, Munehiro
    Morooka, Miyako
    Kubota, Kazuo
    Shimbo, Takuro
    Hiroe, Michiaki
    Noda, Mitsuhiko
    BMJ OPEN, 2011, 1 (02):
  • [23] Smoking and coronary heart disease in patients with type 2 diabetes mellitus
    Kawada, Tomoyuki
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2017, 133 : 211 - 211
  • [24] Erectile dysfunction predicts coronary heart disease in type 2 diabetes
    Ma, Ronald Ching-Wan
    So, Wing-Yee
    Yang, Xilin
    Yu, Linda Wai-Ling
    Kong, Alice Pik-Shan
    Ko, Gary Tin-Choi
    Chow, Chun-Chung
    Cockram, Clive Stewart
    Chan, Juliana Chung-Ngor
    Tong, Peter Chun-Yip
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2008, 51 (21) : 2045 - 2050
  • [25] Is type 2 diabetes really a coronary heart disease risk equivalent?
    Saely, Christoph H.
    Drexel, Heinz
    VASCULAR PHARMACOLOGY, 2013, 59 (1-2) : 11 - 18
  • [26] The Cardiff type 2 diabetes coronary heart disease risk function
    McEwan, P
    Williams, J
    Griffiths, J
    Bagust, A
    Peters, JR
    Hopkinson, P
    Currie, CJ
    DIABETES, 2001, 50 : A461 - A461
  • [27] Myocardial revascularization in patients with coronary heart disease and type 2 diabetes
    Bezdenezhnyh, Natalya A.
    Sumin, Aleksey N.
    DIABETES MELLITUS, 2016, 19 (06): : 471 - 478
  • [28] TF AND TFPI POLYMORPHISMS IN CORONARY HEART DISEASE AND DIABETES TYPE 2
    Opstad, T.
    Pettersen, A. A.
    Akra, S.
    Weiss, T.
    Arnesen, H.
    Seljeflot, I.
    ATHEROSCLEROSIS SUPPLEMENTS, 2010, 11 (02) : 146 - 147
  • [29] Apolipoprotein (a) phenotypes and coronary heart disease in Japanese type 2 diabetes
    Yoshioka, K
    Kamitani, M
    Yoshida, T
    DIABETES, 2000, 49 : A374 - A374
  • [30] Type 2 diabetes and coronary heart disease: Focus on myocardial infarction
    Lago, Rodrigo M.
    Nesto, Richard W.
    CURRENT DIABETES REPORTS, 2009, 9 (01) : 73 - 78
12345